Google Übersetzer
About
Neurotech International Ltd (AU:NTI) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 17 2026
NTI initiates First Clinical Site for Phase 3 ASD Trial
Feb 26 2026
Appendix 4D & Half Year Report
Feb 23 2026
Positive 90-day GLP toxicology study results in non-rodents
Feb 2 2026
Approval received for NTI164 Phase 3 Clinical Study in ASD
Jan 30 2026
Quarterly Activities/Appendix 4C Cash Flow Report
Financials
Revenue
A$7.07 M
Market Cap
A$15.81 M
EPS
0.00